Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Roflumilast |
| Trade Name | |
| Synonyms | B9302-107|BY217|BYK20869|Daliresp|Zoryve |
| Drug Descriptions |
Roflumilast inhibits PDE4D, potentially resulting in decreased tumor cell proliferation and reduced tumor growth (PMID: 39574163). |
| DrugClasses | |
| CAS Registry Number | 162401-32-3 |
| NCIT ID | C76890 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Loncastuximab tesirine-lpyl + Rituximab + Roflumilast | Loncastuximab tesirine-lpyl Rituximab Roflumilast | 0 | 1 |
| Roflumilast | Roflumilast | 0 | 0 |
| Roflumilast + Vemurafenib | Roflumilast Vemurafenib | 1 | 0 |